(WASHINGTON POST)

• Tim Morrison is a senior fellow at the Hudson Institute and former senior director for counterproliferation and biodefense on the National Security Council.

President Trump gets his share of criticism — some warranted, much not. But recently the president’s critics have chosen curious ground to question his response to the coronavirus outbreak since it began spreading from Wuhan, China, in December.

It has been alleged by multiple officials of the Obama administration, including in The Post, that the president and his then-national security adviser, John Bolton, “dissolved the office” at the White House in charge of pandemic preparedness. Because I led the very directorate assigned that mission, the counterproliferation and biodefense office, for a year and then handed it off to another official who still holds the post, I know the charge is specious.

Now, I’m not naive. This is Washington. It’s an election year. Officials out of power want back into power after November. But the middle of a worldwide health emergency is not the time to be making tendentious accusations.

When I joined the National Security Council staff in 2018, I inherited a strong and skilled staff in the counterproliferation and biodefense directorate. This team of national experts together drafted the National Biodefense Strategy of 2018 and an accompanying national security presidential memorandum to implement it; an executive order to modernize influenza vaccines; and coordinated the United States’ response to the Ebola epidemic in Congo, which was ultimately defeated in 2020.

It is true that the Trump administration has seen fit to shrink the NSC staff. But the bloat that occurred under the previous administration clearly needed a correction. Defense Secretary Robert Gates, congressional oversight committees and members of the Obama administration itself all agreed the NSC was too large and too operationally focused (a departure from its traditional role coordinating executive branch activity). As The Post reported in 2015, from the Clinton administration to the Obama administration’s second term, the NSC’s staff “had quadrupled in size, to nearly 400 people.” That is why Trump began streamlining the NSC staff in 2017.

One such move at the NSC was to create the counterproliferation and biodefense directorate, which was the result of consolidating three directorates into one, given the obvious overlap between arms control and nonproliferation, weapons of mass destruction terrorism, and global health and biodefense. It is this reorganization that critics have misconstrued or intentionally misrepresented. If anything, the combined directorate was stronger because related expertise could be commingled.

The reduction of force in the NSC has continued since I departed the White House. But it has left the biodefense staff unaffected — perhaps a recognition of the importance of that mission to the president, who, after all, in 2018 issued a presidential memorandum to finally create real accountability in the federal government’s expansive biodefense system…..